Medical Market Report

Global Human Embryonic Stem Cell (hESC) Market By Type (Totipotent Stem Cell, Pluripotent Stem Cell, and Unipotent Stem Cell), By Application (Research, and Clinical Trials), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139000
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Human Embryonic Stem Cell (hESC) Market is estimated to be valued US$ XX.X million in 2019. The report on Human Embryonic Stem Cell (hESC) Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global human embryonic stem cell (hesc) market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Human Embryonic Stem Cell (hESC) Market Scope:

    By type, the market is segmented into Totipotent Stem Cell, Pluripotent Stem Cell, and Unipotent Stem Cell. By Application, the market is divided into Research, and Clinical Trials.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Astellas Institute of Regenerative Medicine (US), Asterias Biotherapeutics Inc. (US), BD Biosciences (US), Cell Cure Neurosciences Ltd. (Israel), Cellular Dynamics International (US), GE Healthcare (UK), MilliporeSigma (US), PerkinElmer Inc. (US), Reliance Life Sciences Ltd. (India), Research & Diagnostics Systems Inc. (US), SABiosciences Corp. (US), STEMCELL Technologies Inc. (Canada), Stemina Biomarker Discovery Inc. (US), Takara Bio Inc. (Japan), TATAA Biocenter AB (Sweden), Thermo Fisher Scientific Inc. (US), UK Stem Cell Bank (UK), ViaCyte Inc. (US), and Vitrolife AB (Sweden).

    Key Market Segments

    Type

    Totipotent Stem Cell

    Pluripotent Stem Cell

    Unipotent Stem Cell

    Application

    Research

    Clinical Trials

    Key Market Players included in the report:

    Astellas Institute of Regenerative Medicine (US)

    Asterias Biotherapeutics Inc. (US)

    BD Biosciences (US)

    Cell Cure Neurosciences Ltd. (Israel)

    Cellular Dynamics International (US)

    GE Healthcare (UK)

    MilliporeSigma (US)

    PerkinElmer Inc. (US)

    Reliance Life Sciences Ltd. (India)

    Research & Diagnostics Systems Inc. (US)

    SABiosciences Corp. (US)

    STEMCELL Technologies Inc. (Canada)

    Stemina Biomarker Discovery Inc. (US)

    Takara Bio Inc. (Japan)

    TATAA Biocenter AB (Sweden)

    Thermo Fisher Scientific Inc. (US)

    UK Stem Cell Bank (UK)

    ViaCyte Inc. (US)

    Vitrolife AB (Sweden)

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Human Embryonic Stem Cell (hESC) Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Human Embryonic Stem Cell (hESC) Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Human Embryonic Stem Cell (hESC) Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Human Embryonic Stem Cell (hESC) Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Human Embryonic Stem Cell (hESC) Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Human Embryonic Stem Cell (hESC) Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Human Embryonic Stem Cell (hESC) sub-markets, depending on key regions (various vital states).
    To analyze Human Embryonic Stem Cell (hESC) Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Human Embryonic Stem Cell (hESC) Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Human Embryonic Stem Cell (hESC) Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Human Embryonic Stem Cell (hESC) Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Human Embryonic Stem Cell (hESC) Market Overview
    

    3.1. Human Embryonic Stem Cell (hESC) Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Human Embryonic Stem Cell (hESC) Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Human Embryonic Stem Cell (hESC) Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Totipotent Stem Cell
    

      4.4. Pluripotent Stem Cell
    

      4.5. Unipotent Stem Cell
    

    5. Global Human Embryonic Stem Cell (hESC) Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Human Embryonic Stem Cell (hESC) Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Research
    

      5.4. Clinical Trials
    

    6. Global Human Embryonic Stem Cell (hESC) Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Human Embryonic Stem Cell (hESC) Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Human Embryonic Stem Cell (hESC) Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Human Embryonic Stem Cell (hESC) Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Human Embryonic Stem Cell (hESC) Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Human Embryonic Stem Cell (hESC) Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Human Embryonic Stem Cell (hESC) Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Astellas Institute of Regenerative Medicine (US)
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Asterias Biotherapeutics#Inc. (US)
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. BD Biosciences (US)
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Cell Cure Neurosciences Ltd. (Israel)
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Cellular Dynamics International (US)
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. GE Healthcare (UK)
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. MilliporeSigma (US)
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. PerkinElmer#Inc. (US)
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Reliance Life Sciences Ltd. (India)
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Research & Diagnostics Systems#Inc. (US)
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. SABiosciences Corp. (US)
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. STEMCELL Technologies#Inc. (Canada)
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

      7.15. Stemina Biomarker Discovery#Inc. (US)
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
    

      7.16. Takara Bio#Inc. (Japan)
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
    

      7.17. TATAA Biocenter AB (Sweden)
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments
    

      7.18. Thermo Fisher Scientific#Inc. (US)
    

        7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments
    

      7.19. UK Stem Cell Bank (UK)
    

        7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments
    

      7.20. ViaCyte#Inc. (US)
    

        7.20.1. Company Overview
    
    7.20.2. Financial Highlights
    
    7.20.3. Product Portfolio
    
    7.20.4. SWOT Analysis
    
    7.20.5. Key Strategies and Developments
    

      7.21. Vitrolife AB (Sweden)
    

        7.21.1. Company Overview
    
    7.21.2. Financial Highlights
    
    7.21.3. Product Portfolio
    
    7.21.4. SWOT Analysis
    
    7.21.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.